Skip to main navigation

About
- About
- Contact Us
Pipeline
Science
- Science
- DKK1
- DKN-01
- Claudin18.2
- GDF15
Patients
- Patients
- Expanded Access
Careers
Investors

News
Releases

image description

News Releases

Year

Jan 17, 2023

Leap Therapeutics Acquires Flame Biosciences

Jan 11, 2023

Leap Therapeutics to Present at B. Riley Securities' 3rd Annual Oncology Conference

First page
Previous page
Page 1
Current page 2

Print Page
Email Alerts
Contact Us

image description

image description

47 Thorndike Street, Suite B1-1 Cambridge, MA 02141 USA

+1 617 714 0360

Business inquiries
bd@leaptx.com

Investor inquiries
ir@leaptx.com

ABOUT
CONTACT US

CAREERS

PIPELINE
DKN-01 PROGRAMS
ANTI-CLDN18.2 PROGRAMS
FL-501

PATIENTS
EXPANDED ACCESS

SCIENCE
DKK1
DKN-01
CLAUDIN18.2
GDF15

INVESTORS
STOCK INFORMATION
NEWS RELEASES
PRESENTATIONS & EVENTS
FINANCIAL INFORMATION
CORPORATE GOVERNANCE
INFORMATION REQUEST

© 2023 Leap Therapeutics, Inc.
All Rights Reserved.

Terms of Use
Privacy Policy
Cookie Policy